-
.
Soluble Tim-3 serves as a tumor prognostic marker and therapeutic target for CD8 + T cell exhaustion and anti-PD-1 resistance.
CELL REPORTS MEDICINE,
5,
2024.
-
.
Urolithin A Hijacks ERK1/2-ULK1 Cascade to Improve CD8+ T Cell Fitness for Antitumor Immunity.
Advanced Science,
2024.
-
.
Identification of a small-molecule Tim-3 inhibitor to potentiate T cell-mediated antitumor immunotherapy in preclinical mouse models.
SCIENCE TRANSLATIONAL MEDICINE,
15,
2024.
-
张言坤.
ZHX2 emerges as a negative regulator of mitochondrial oxidative phosphorylation during acute liver injury.
NATURE COMMUNICATIONS,
14,
2024.
-
秦丽萍.
CRL4B complex-mediated H2AK119 monoubiquitination restrains Th1 and Th2 cell differentiation.
Cell Death and Differentiation,
30,
1488-1502,
2024.
